Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6250626 | 7036942 | I | 6250626-8 | 20090619 | 20090630 | EXP | CA-AMGEN-QUU352508 | AMGENSAFETY | F | Y | 20090630 | MD | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6250626 | 1011812028 | PS | NEULASTA | 1 | UNKNOWN | NOT PROVIDED | |||||
| 6250626 | 1011812029 | C | DOXORUBICIN HYDROCHLORIDE | 1 | |||||||
| 6250626 | 1011812030 | C | CYCLOPHOSPHAMIDE | 2 | |||||||
| 6250626 | 1011812031 | C | DOCETAXEL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6250626 | 1011812028 | CHEMOTHERAPY |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6250626 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6250626 | FEBRILE NEUTROPENIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |